Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹16 Cr₹11 Cr₹11 Cr₹-0.68 Cr₹3.63 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES ?

The latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES is ₹16 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹16 Cr
Mar2024₹11 Cr
Mar2023₹11 Cr
Mar2022₹-0.68 Cr
Mar2021₹3.63 Cr

How is Deferred Tax Assets / Liabilities of VENUS REMEDIES Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹16 Cr
42.73
Mar2024 ₹11 Cr
2.54
Mar2023 ₹11 Cr
Positive
Mar2022 ₹-0.68 Cr
Negative
Mar2021 ₹3.63 Cr -

Compare Deferred Tax Assets / Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹606.7 Cr -1.7% -4.1% 25.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹387,792.0 Cr 2.3% -0.4% -12.4% Stock Analytics
DIVIS LABORATORIES ₹159,986.0 Cr 0% 1.1% 10.7% Stock Analytics
CIPLA ₹127,124.0 Cr 2.1% 3.5% -4.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,700.0 Cr -1.2% -1.7% 4.5% Stock Analytics
DR REDDYS LABORATORIES ₹109,868.0 Cr 5.3% 7.9% -2% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-1.7%

-4.1%

25.1%

SENSEX

1.5%

1.6%

0.4%


You may also like the below Video Courses